Malaria | Brain cancer

Antibody treatment protects adults against malaria; customized drug to kill brain cancer cells; learning to control microglia using CRISPR

Having trouble viewing this email? View it as a Web page.

August 23, 2022 Edition

Silhouette of mosquito on human skin at sunset

Antibody treatment protects adults against malaria

A single low dose of an experimental monoclonal antibody safely and effectively prevented malaria infection in a small clinical trial.

Illustration of DNA helix broken in the middle

Customized drug to kill brain cancer cells

Researchers designed a new type of drug that causes lethal DNA damage in a type of brain cancer called glioblastoma, but not in normal cells.

Illustration of microglia among long neuron projections

Learning to control microglia using CRISPR

Researchers used CRISPR tools to identify genes controlling cells in the brain called microglia, which are involved in Alzheimers disease and other brain disorders.

Connect with us:

Facebook

RSS Feed

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612

August 23, 2022 Edition

Antibody treatment protects adults against malaria

Customized drug to kill brain cancer cells

Learning to control microglia using CRISPR

Popular Stories:

Connect with us: